Novartis Access – Need for social metrics
Professor Richard Laing, an expert on access-to-medicine programs, says the pharma industry needs to better measure the impact of our programs. Here... Learn More
Novartis Access – measuring the impact
Professor Richard Laing, an expert on access-to-medicine programs, says the pharma industry needs to better measure the impact of our programs. So... Learn More
Novartis Community Partnership Day – 1997
Our global volunteer activity takes the form of Community Partnership Day, an initiative replicated by Novartis Group company sites every year, which... Learn More
The patient perspective on heart failure
Heart failure impacts more than 60 million people worldwide. Here, people with heart failure share insights into their symptoms, diagnosis and how... Learn More
Novartis Australia – Great Place to work September 2016 – October 2017
Novartis Australia is proud to be recognised as a great place to work. To learn more visit: www.novartis.com.au © 2017 Novartis AG
Advances in MS
Norman Putzki, Vice President and Medical Unit Head, Neuroscience, Novartis, explains how we are working to address unmet needs in MS management.... Learn More
Using gene therapy for hearing loss
Susan Stevenson, a researcher in the New Indications Discovery Unit, discusses her work using atonal gene therapy to regenerate lost inner ear... Learn More
Targeting an undruggable oncology target
Patrick Chene, a researcher in Oncology, discusses why he’s inspired seeing a compound move to the clinic, and the committed, multidisciplinary teams... Learn More
Solving a cancer puzzle
Our structural biologists love puzzles and achieving what hasn’t been done before, such as creating a molecular glue that shuts down a... Learn More
Meet with David Hughes from the Novartis Malaria Initiative team
We are proud of the passion of our people and their dedication to the fight against malaria. Meet with David Hughes, Senior... Learn More
Meet with Thierry Diagana from the Novartis Malaria Initiative team
We are proud of the passion of our people and their dedication to the fight against malaria. Meet with Thierry Diagana, Head... Learn More
Together we can end malaria for good
We are proud of the passion of our people and their dedication to the fight against malaria. Meet some of the faces... Learn More
Meet with Nathan Mulure from the Novartis Malaria Initiative team
We are proud of the passion of our people and their dedication to the fight against malaria. Meet with Nathan Mulure, Head... Learn More
Meet with Rebecca Stevens from the Novartis Malaria Initiative team
We are proud of the passion of our people and their dedication to the fight against malaria. Meet with Rebecca Stevens, Head... Learn More
Together we are stronger than SJIA
Parents of children living with Systemic Juvenile Idiopathic Arthritis (SJIA), a rare form of childhood arthritis, offer words of encouragement to families... Learn More
Navigate NET: The Road to Diagnosis
Neuroendocrine tumors (NET) are a rare type of cancer that can occur throughout the body. Learn more about NET in this animated... Learn More
Experts gather to explore response to chronic illness in poor countries
On November 29, global health experts from the Novartis Foundation, Novartis Access, NGOs and academia gathered at our Basel headquarters to discuss... Learn More
Voices of the Acromegaly Community: Putting the Spotlight on a Rare Disease
In this video, learn more about acromegaly, a rare hormonal disorder, from patients discussing their experiences living with and managing the condition,... Learn More
Tackling chronic disease with Novartis Access
Chronic diseases like high blood pressure and diabetes impact more than just wealthy nations. Through the Novartis Foundation and Novartis Access, we’re... Learn More
Multidisciplinary NET Discussion Video – Part Three: Specialized NET Care
The management of neuroendocrine tumors (NET), a rare type of cancer, typically involves a team of various specialists. In the final chapter... Learn More
Multidisciplinary NET Discussion Video – Part One: Uncovering NET
The management of neuroendocrine tumors (NET), a rare type of cancer, typically involves a team of various specialists. In the first chapter... Learn More
Multidisciplinary NET Discussion Video – Part Two: Living with NET
The management of neuroendocrine tumors (NET), a rare type of cancer, typically involves a team of various specialists. In the second chapter... Learn More
Results from the First Global NET Survey – Part 3: Multidisciplinary Care in NET
How can a multidisciplinary team (MDT) and a specialized NET treatment center help improve the care and experience of patients living with... Learn More
Results from the First Global NET Survey – Part 2: The NET Patient Experience
Neuroendocrine tumors, or NET, are a rare type of cancer that can occur throughout the body. Learn about the impact of NET... Learn More
Results from the First Global NET Survey – Part 1: Time to Diagnosis
Patients with neuroendocrine tumors (NET) often remain undiagnosed for years due to vague signs or symptoms, or even a lack of symptoms.... Learn More
NET by the Numbers
This animated narrative uniquely portrays the journey of patients living with neuroendocrine tumors (NET) through key findings from the Global NET Survey.... Learn More
The making of the ‘Make Time’ Clock Heart Sculpture
Now is the TIME to do more for people living with heart failure. This was an important message that was brought to... Learn More
Next Generation Scientists 2016
The Novartis and University of Basel Next Generation Scientists program aims to increase the volume of drug discovery and clinical research in... Learn More
Novartis Access in Kenya – full version
An inside look at Novartis Access in Kenya. Novartis Access focuses on the affordability and availability of on- and off-patent medicines addressing... Learn More
Novartis Access in Kenya – highlights version
An inside look at Novartis Access in Kenya. Novartis Access focuses on the affordability and availability of on- and off-patent medicines addressing... Learn More
Behind the scenes – the making of “A Clear View of Psoriasis”
What is it like to live with psoriasis? We worked with artist Natalie Fletcher to bring these hopes and stories to life... Learn More
Clear about Psoriasis Survey – Bodypainting
The Clear about Psoriasis survey identified 8,300 patients from around the world and revealed their hopes of living with clear skin. We... Learn More
Set Your Sights on Glaucoma Awareness
With glaucoma, vision loss could lead to irreversible blindness. Fortunately, early detection will help slow down the progression of glaucoma and can... Learn More
NET Fusion Animated Video
This animated video is part of the NET Fusion campaign, which explains carcinoid syndrome and how nutrition plays a role in disease... Learn More
A Clear View of Psoriasis
What is it like to live with psoriasis? In partnership with patient advocacy groups, we surveyed over 8,000 patients about how it... Learn More
Understanding Immune Thrombocytopenia: Perspectives in ITP
Immune Thrombocytopenia (ITP) is an autoimmune disease characterized by the improper functioning or destruction of platelets. Learn more about this rare disease... Learn More
Demystifying Migraine
Migraine is more than just a headache. It is a disabling neurological condition, associated with substantial personal suffering, reduced quality of life... Learn More
Acute Myeloid Leukemia: Unique Needs for Patients and Caregivers
An interview with Chris West, Head of Media and Public Affairs at Bloodwise, UK, discussing acute myeloid leukemia (AML) and patient and... Learn More
MS, Life & Treatment
Norman Putzki, Global Program Head of Neuroscience, Novartis, explains how taking medicine as prescribed can help those living with Multiple Sclerosis. ©... Learn More
Novartis International BioCamp 2016
The Novartis International BioCamp is a three-day biotechnology seminar for top graduate and postgraduate students interested in a career in biotechnology. Participants... Learn More
The McCourty Twins Tackle Sickle Cell & Iron Overload
Devin and Jason McCourty, professional football players and identical twins, have teamed up with Novartis to talk about the importance of managing... Learn More
Novartis International BioCamp Alumni Perspective: Eli
BioCamp 2014 alumnus Eli Goldberg shares what made his BioCamp experience memorable. © 2016 Novartis AG
Novartis Access – World Health Assembly Event
In May, Novartis Access held an event to discuss how partnerships can help expand access to affordable NCD medicines for populations at... Learn More
Novartis Next Generation Scientists Director on building scientific capability
Colin Pillai, Director of Novartis’s Next Generation Scientists program, found his calling for very personal reasons. Learn why he’s passionate about building... Learn More
Museum of MS – Vraj’s Story on Life with Multiple Sclerosis
Welcome to the Museum of MS, a place where positive experiences are shared. After his second multiple sclerosis relapse, Vraj said, “I... Learn More
What is Next Generation Scientists?
Developing next generation medicines requires next generation scientists – that’s why Novartis invites talented young scientists from developing countries worldwide to our... Learn More
The Role of Interleukin-1 (IL-1) in Two Rare Autoinflammatory Diseases
Cryopyrin-Associated Periodic Syndromes (CAPS) and Systemic Juvenile Idiopathic Arthritis (SJIA) are autoinflammatory diseases marked by an overproduction of Interleukin-1ß (IL-1ß), a protein... Learn More
What are the symptoms and complications of polycythemia vera?
This video features Dr. Ruben Mesa explaining the symptoms and complications of polycythemia vera, a rare blood cancer. For more information, please... Learn More
How is polycythemia vera diagnosed?
This video features Dr. Claire Harrison explaining how polycythemia vera, a rare blood cancer, is diagnosed. For more information, please visit http://www.novartis.com.... Learn More
What is polycythemia vera?
This video features Dr. Ruben Mesa providing an overview of polycythemia vera, a rare blood cancer. For more information, please visit http://www.novartis.com.... Learn More
Harnessing the Science of Immuno-oncology at Novartis
Our immuno-oncology researchers are rapidly making discoveries about how cancers trip up our immune systems. Potential medicines that we’re developing aim put... Learn More
Novartis mission
Our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s... Learn More
COPD exacerbations: real stories
How do chronic obstructive pulmonary disease (COPD) flare-ups affect the life of people living with the disease? Listen to these real stories... Learn More
Understanding COPD and the impact of disease flare-ups
Chronic obstructive pulmonary disease (COPD) is a progressive disease that obstructs airways and leads to difficulties in breathing. COPD symptoms might suddenly... Learn More